» Articles » PMID: 17311311

Neurotrophic Effects of GM1 Ganglioside and Electrical Stimulation on Cochlear Spiral Ganglion Neurons in Cats Deafened As Neonates

Overview
Journal J Comp Neurol
Specialty Neurology
Date 2007 Feb 22
PMID 17311311
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown that electrical stimulation of the cochlea by a cochlear implant promotes increased survival of spiral ganglion (SG) neurons in animals deafened early in life (Leake et al. [1999] J Comp Neurol 412:543-562). However, electrical stimulation only partially prevents SG degeneration after deafening and other neurotrophic agents that may be used along with an implant are of great interest. GM1 ganglioside is a glycosphingolipid that has been reported to be beneficial in treating stroke, spinal cord injuries, and Alzheimer's disease. GM1 activates trkB signaling and potentiates neurotrophins, and exogenous administration of GM1 has been shown to reduce SG degeneration after hearing loss. In the present study, animals were deafened as neonates and received daily injections of GM1, beginning either at birth or after animals were deafened and continuing until the time of cochlear implantation. GM1-treated and deafened control groups were examined at 7-8 weeks of age; additional GM1 and no-GM1 deafened control groups received a cochlear implant at 7-8 weeks of age and at least 6 months of unilateral electrical stimulation. Electrical stimulation elicited a significant trophic effect in both the GM1 group and the no-GM1 group as compared to the contralateral, nonstimulated ears. The results also demonstrated a modest initial improvement in SG density with GM1 treatment, which was maintained by and additive with the trophic effect of subsequent electrical stimulation. However, in the deafened ears contralateral to the implant SG soma size was severely reduced several months after withdrawal of GM1 in the absence of electrical activation.

Citing Articles

Decreasing the physical gap in the neural-electrode interface and related concepts to improve cochlear implant performance.

Vecchi J, Claussen A, Hansen M Front Neurosci. 2024; 18:1425226.

PMID: 39114486 PMC: 11303154. DOI: 10.3389/fnins.2024.1425226.


Closing the Gap between the Auditory Nerve and Cochlear Implant Electrodes: Which Neurotrophin Cocktail Performs Best for Axonal Outgrowth and Is Electrical Stimulation Beneficial?.

Schmidbauer D, Fink S, Rousset F, Lowenheim H, Senn P, Glueckert R Int J Mol Sci. 2023; 24(3).

PMID: 36768339 PMC: 9916558. DOI: 10.3390/ijms24032013.


AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Leake P, Rebscher S, Dore C, Akil O J Assoc Res Otolaryngol. 2019; 20(4):341-361.

PMID: 31222416 PMC: 6646500. DOI: 10.1007/s10162-019-00723-5.


Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase.

Henriques A, Croixmarie V, Priestman D, Rosenbohm A, Dirrig-Grosch S, DAmbra E Hum Mol Genet. 2015; 24(25):7390-405.

PMID: 26483191 PMC: 4664174. DOI: 10.1093/hmg/ddv439.


Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.

Leake P, Stakhovskaya O, Hetherington A, Rebscher S, Bonham B J Assoc Res Otolaryngol. 2013; 14(2):187-211.

PMID: 23392612 PMC: 3660916. DOI: 10.1007/s10162-013-0372-5.


References
1.
Miller J, Chi D, OKeeffe L, Kruszka P, Raphael Y, Altschuler R . Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci. 1997; 15(4-5):631-43. DOI: 10.1016/s0736-5748(96)00117-7. View

2.
Fighera M, Royes L, Furian A, Oliveira M, Fiorenza N, Frussa-Filho R . GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol Dis. 2006; 22(3):611-23. DOI: 10.1016/j.nbd.2006.01.002. View

3.
Staecker H, Kopke R, Malgrange B, Lefebvre P, Van De Water T . NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport. 1996; 7(4):889-94. DOI: 10.1097/00001756-199603220-00011. View

4.
Leake P, Snyder R, Hradek G, Rebscher S . Chronic intracochlear electrical stimulation in neonatally deafened cats: effects of intensity and stimulating electrode location. Hear Res. 1992; 64(1):99-117. DOI: 10.1016/0378-5955(92)90172-j. View

5.
Leake P, Snyder R, Rebscher S, Moore C, Vollmer M . Plasticity in central representations in the inferior colliculus induced by chronic single- vs. two-channel electrical stimulation by a cochlear implant after neonatal deafness. Hear Res. 2000; 147(1-2):221-41. DOI: 10.1016/s0378-5955(00)00133-7. View